Biospectrum Asia, Singapore develops oral-anti-diabetic drug

The article shared that Singapore has completed phase I clinical trial of an oral-anti-diabetic drug        developed by Department of Pharmacology of the NUS Yong Loo Lin School of medicine (NUS Medicine) together with Singapore Clinical Research Institute and National University Health System (NUHS). The drug, DAA-I’s mechanism, impact and future plans were also touched on in the article.

Read More : Singapore develops oral-anti-diabetic drug